Medical imaging plays a critical role in modern diagnosis and treatment planning, and contrast media are essential for enhancing image clarity and diagnostic accuracy across radiology and interventional procedures. Zhejiang Haizhou Pharmaceutical has built strong expertise in the contrast media value chain, supplying key products including Iobitridol, Iodixanol, Iohexol, Iomeprol, Iopamidol, Iopromide, Ioversol, as well as advanced MRI contrast agents such as Gadobutrol, Gadoterate Meglumine, Gadoteridol, and Gadoxetate Disodium. Leveraging more than 50 years of pharmaceutical manufacturing experience, the company combines deep knowledge of iodine contrast media and specialty pharmaceutical chemistry with advanced production technologies and stringent quality systems. Supported by cGMP-compliant facilities and international approvals from NMPA, US FDA, and EDQM, Haizhou Pharm provides reliable APIs, intermediates, and custom manufacturing solutions that help global pharmaceutical partners deliver high-performance diagnostic imaging products to healthcare professionals worldwide.